Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

12.71 +0.03 (+0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
QuidelOrtho Corp (NASDAQ:QDEL) Beats Q4 Earnings Estimates Despite After-Hours Stock Decline ↗
Via Chartmill
News headline image
Wednesday's after hours session: top gainers and losers ↗
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
1 Stock Under $50 with Impressive Fundamentals and 2 We Question
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci... 
Via StockStory
Topics Government Stocks
News headline image
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t... 
Via StockStory
News headline image
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Artificial Intelligence Government Stocks
News headline image
Rice Hall James Buys QuidelOrtho Stock ↗
QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Unprofitable Stocks That Concern Us
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding... 
Via StockStory
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
News headline image
QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, QuidelOrtho’s shares (currently trading at $22.11) have posted a disappointing 19.9% loss, well below the S&P 500’s 6.6% gain. This... 
Via StockStory
Topics Stocks
News headline image
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires ↗
QuidelOrtho Corporation's stock has been falling for multiple years, but after a board member purchased shares, could the stock soon reverse? 
Via The Motley Fool
Topics Regulatory Compliance Retirement Workforce
News headline image
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Economy Government World Trade
News headline image
1 Russell 2000 Stock to Keep an Eye On and 2 We Brush Off
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗
Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide. 
Via The Motley Fool
News headline image
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗
Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗
Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗
Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Small-Cap Stocks We Approach with Caution
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
The Top 5 Analyst Questions From QuidelOrtho’s Q4 Earnings Call
QuidelOrtho’s fourth quarter was marked by improved operational efficiency and growth in its core labs and non-respiratory businesses, but the market responded negatively to its results. Management... 
Via StockStory
Topics Earnings World Trade
News headline image
QDEL Stock Slumps On Mixed Wall Street Price Target Revisions After Q4 Report ↗
UBS, Citi and JPMorgan revised their price targets on the stock on the heels of the company issuing fresh guidance for fiscal 2026. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
QDEL Q4 Deep Dive: Margin Expansion, R&D Pipeline, and Guidance Disappoints
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s... 
Via StockStory
Topics Economy World Trade
News headline image
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript ↗
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s... 
Via StockStory
News headline image
Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Wednesday after the bell. Here’s what to expect. 
Via StockStory
Topics World Trade
News headline image
3 Volatile Stocks We’re Skeptical Of
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
3 Stocks Under $50 Walking a Fine Line
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.